Thompson J W, Ware M R, Blashfield R K
Department of Psychiatry, University of Florida, Gainesville.
J Clin Psychiatry. 1990 Oct;51(10):430-3.
Numerous reports have emphasized the association between priapism and the ingestion of psychotropic medication. Clinicians are becoming increasingly aware of this association and its subsequent severe morbidity. Review of the literature reveals that medications possessing alpha-adrenergic blocking properties are most frequently associated with priapism. These medications include trazodone, several antipsychotics, and the antihypertensive agent, prazosin. Awareness of these associations and an appreciation of potentially serious consequences of this disorder may assist clinicians in choosing psychotropic agents that minimize the risk of developing priapism. It is essential that patients who are to receive psychotropic medications be forewarned about priapism. In addition, patients should be questioned concerning prior occurrence of prolonged erections, since a past history of delayed detumescence is present in approximately 50% of subsequent cases of priapism.
众多报告强调了阴茎异常勃起与精神类药物摄入之间的关联。临床医生越来越意识到这种关联及其随后的严重发病率。文献回顾显示,具有α-肾上腺素能阻断特性的药物最常与阴茎异常勃起相关。这些药物包括曲唑酮、几种抗精神病药物以及抗高血压药物哌唑嗪。了解这些关联以及认识到这种疾病可能产生的严重后果,可能有助于临床医生选择能将发生阴茎异常勃起风险降至最低的精神类药物。必须预先警告即将接受精神类药物治疗的患者有关阴茎异常勃起的情况。此外,应询问患者既往是否有长时间勃起的情况,因为在随后约50%的阴茎异常勃起病例中存在阴茎消肿延迟的既往史。